FOLH1 and posterior cortical atrophy: Despite the emergence of novel therapeutic approaches including androgen deprivation therapy (ADT) 1 and investigational prostate specific membrane antigen (PSMA)-targeted alpha- and beta-particle radioligand therapies (RLT) 2-15, advanced PCa remains invariably lethal 16.